Biotech Stock Review

Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.

First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
Richard Werner

Video: How the Bank of Japan Created a Massive Bubble That Blew Up.

Fascinating video documentary 'Princes of the Yen: Central Bank Truths' with Banking Expert and Oxford Professor Richard Werner. Werner believes that Central...

Remember this?

What once looked liked a barrel of fun, now looks like shark infested waters. @chuttersnap
Staley Drukenmiller

Video: Stanley Druckenmiller, Bearish in 2018.

https://youtu.be/G-MlrpoMig0 "What would you need to see to give you the conviction to want to go short?"At the 53:51 mark!  

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...